RELIEF THERAPEUTICS Holding SA - ESG Rating & Company Profile powered by AI
If you work at RELIEF THERAPEUTICS Holding SA and you would like to use your Sustainability aseessment, please get in touch. Complete Sustainability analysis of RELIEF THERAPEUTICS Holding SA can be reached by signing up for free. This assessment of RELIEF THERAPEUTICS Holding SA was prepared by All Street Sevva using advanced artificial intelligence.
RELIEF THERAPEUTICS Holding SA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 1.6, social score of 3.2 and governance score of 6.7.
3.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1476 | Philogen SpA | 3.9 | Medium |
| 1476 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd | 3.9 | Medium |
| 1512 | RELIEF THERAPEUTICS Holding SA | 3.8 | Medium |
| 1512 | Ampio Pharmaceuticals Inc | 3.8 | Medium |
| 1512 | Abeona Therapeutics Inc | 3.8 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does RELIEF THERAPEUTICS Holding SA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose current and historical energy intensity?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA report the average age of the workforce?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose its ethnicity pay gap?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose cybersecurity risks?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA offer flexible work?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA conduct supply chain audits?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA conduct 360 degree staff reviews?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose the individual responsible for D&I?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose water use targets?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA have careers partnerships with academic institutions?
Sign up for free to unlockDid RELIEF THERAPEUTICS Holding SA have a product recall in the last two years?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose incidents of discrimination?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas RELIEF THERAPEUTICS Holding SA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose parental leave metrics?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose the pay ratio of women to men?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs RELIEF THERAPEUTICS Holding SA involved in embryonic stem cell research?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose its waste policy?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA report according to TCFD requirements?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose energy use targets?
Sign up for free to unlockDoes RELIEF THERAPEUTICS Holding SA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes RELIEF THERAPEUTICS Holding SA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for RELIEF THERAPEUTICS Holding SA
These potential risks are based on the size, segment and geographies of the company.
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company focuses on clinical-stage programs based on molecules with a history of clinical use and either initial human activity or efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action for respiratory indications, which is in Phase 3 clinical trials for treating COVID-19-induced acute respiratory distress syndrome and moderate to severe COVID-19 lung injury; in Phase 1 clinical trial for the treatment of patients with acute lung injury in other intensive care unit; and in Phase 2 clinical trial for the treatment of pulmonary sarcoidosis. The company is also developing ACER-001, a proprietary powder formulation of sodium phenylbutyrate, which has completed Phase 3 clinical trial for urea cycle disorders; and in Phase 1 clinical trial for the treatment of maple syrup urine disease. In addition, it is developing APR-TD011, a spray-formulated hypotonic acid-oxidizing solution, which is in Phase 2 clinical trial for treating epidermolysis bullosa. The company was founded in 2013 and is based in Geneva, Switzerland.